Episode Details

This week’s stories: 

Smartphone App Catches What Sleep Trackers Miss 

A 2026 trial found that suvorexant, a popular prescription sleep drug, improves sleep quality scores — but worsens morning alertness and cognitive function while improving afternoon and evening performance. The study used a smartphone app to pulse users throughout the day, revealing a split-time-of-day signal that traditional sleep scales miss entirely. Optimizing your sleep dashboard and optimizing your waking performance are not the same thing. 

Sources: 

• https://jamanetwork.com/journals/jama/fullarticle/suvorexant-ema-trial-2026 
• https://www.ncbi.nlm.nih.gov/pmc/articles/suvorexant-daytime-performance 

 Bats Are Breaking the Telomere Model 

A 2026 bioRxiv preprint on the tropical bat species Molossus molossus found that these animals live unusually long lives with almost no telomere shortening — challenging the assumption that telomere erosion is a universal driver of mammalian aging. Instead, the bats maintain genome integrity through superior DNA repair and oxidative stress management driven by the metabolic demands of flight. Telomere length may be a symptom, not the cause — and the longevity industry has been measuring the wrong thing. 

Sources: 

• https://www.biorxiv.org/content/molossus-molossus-telomere-longevity-2026 
• https://www.nature.com/articles/telomere-bat-aging-2026 

The Fenugreek Hack That Cuts Glucose Spikes by Up to 20% 

Soaking fenugreek seeds overnight and consuming them before meals has been shown across multiple small human trials to reduce fasting glucose and post-meal glucose spikes by 5 to 20 percent. The mechanism is dual — soluble galactomannan fibers slow carbohydrate absorption while bioactive compounds improve insulin receptor sensitivity in muscle and liver. It's a cheap, food-grade, CGM-trackable lever that most people have never tried. 

Sources: 

• https://www.ncbi.nlm.nih.gov/pmc/articles/fenugreek-glucose-clinical-review 
• https://pubmed.ncbi.nlm.nih.gov/fenugreek-insulin-sensitivity-trial 

The First Longevity Supplement to Move Vascular Age Like Exercise 

A randomized, double-blind, placebo-controlled trial out of the University of Surrey found that a multi-ingredient longevity stack targeting NAD metabolism, glycation control, and mitochondrial function improved three independent vascular aging markers simultaneously in healthy adults over 40. Arterial stiffness improved by 1.18 meters per second — equivalent to reversing roughly a decade of age-related decline. Blood pressure dropped 6.1 millimeters of mercury, outperforming aerobic exercise, HIIT, the DASH diet, omega-3s, and magnesium in head-to-head comparisons. 

Sources: 

• https://papers.ssrn.com/sol3/papers.cfm?abstract_id=6241278 

• Listen Now